Genmab — Maj 2021
-
Aktier/åbning: Sur start på dagen med pres på Vestas og Ambu:
https://www.proinvestor.com/investornyt/674920/aktier-abning-sur-start-pa-dagen-med-pres-pa-vestas-og-ambu -
-
Researchers find CD38-targeting drugs may show promise against prostate cancer http://www.pharmatimes.com/news/researchers_find_cd38-targeting_drugs_may_show_promise_against_prostate_cancer_1369656
-
"The study suggests that CD38-targeting therapies, including Janssen’s multiple myeloma drug Darzalex (daratumumab), may therefore offer a promising new treatment type for prostate cancer patients".
-
-
they are also running prostate c trials now in the UK according to this
- New type of treatment could reawaken immune response against prostate cancer https://www.icr.ac.uk/news-archive/new-type-of-treatment-could-reawaken-immune-response-against-prostate-cancer which follows this publication - https://www.sciencedirect.com/science/article/pii/S0302283821000221?via%3Dihub
-
GEN is doing relatively well today - could we be seeing a bit of Asco build-up?
-
It would be nice with signs of life from Europes second best biotech…
-
The best one has decided to build af factory - https://www.wsj.com/articles/biontech-to-make-covid-19-vaccines-in-singapore-11620624600
-
Q1 webcast: Se Genmabs ledelse i Q&A med analytikere https://www.proinvestor.com/investornyt/674947/q1-webcast-se-genmabs-ledelse-i-qampa-med-analytikere
-
Spørgsmål til Q&A er meget velkommen.
-
Lidt om Amivantamab https://www.jbc.org/article/S0021-9258(21)00427-0/fulltext
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind